Amantadine and COVID-19

Participate in this study and help us discover the role of Amantadine as a therapeutic alternative to fight COVID-19


Are you a Parkinson’s or Multiple Sclerosis patient under amantadine treatment? In that case, join the study and help us improve the treatment against COVID-19!

Contact with us!

Besides, if you are interested in obtaining more information or have any questions, please contact investigacion@acbgestionsanitaria.com

Description of the Study:

  • Title: Relationship Between Amantadine and COVID-19 in Patients with Parkinson’s Disease or Multiple Sclerosis.
  • Principal Investigator: Albert Cortés Borra.
  • Co-Investigators: Dr. José Ramón Martínez Riera, José Manuel Viturro Iglesias,  Dr. Fernando Martínez Cuervo.
  • Centers of Implementation: Vall d’Hebron Hospital, Centro Polivalente de Recursos para Personas Mayores El Cristo.
  • Design: Observational study.

Objectives of the Study:

Principal Objective: This research aims to demonstrate that amantadine exerts a protective factor against COVID-19 in patients who have been under treatment with the aforementioned antiviral to alleviate the symptoms of their neurological disease.

Secondary Objective: Open therapeutic and prophylactic alternatives to COVID-19 infection.

More about this Study:

Patients with Parkinson’s disease or multiple sclerosis have amantadine among the multiple therapeutic arsenals available under the supervision of their specialist. However, why not study if amantadine could also be used to treat COVID-19?

Amantadine is used to treat the symptoms of Parkinson’s disease, Multiple Sclerosis, and similar conditions. Besides, it is also used to control movement problems that are side effects of certain medications used to treat Parkinson’s disease. Moreover, it can also prevent symptoms of influenza A virus infection and to treat respiratory infections caused by Type A influenza virus.

In fact, Amantadine is in a class of medications called adamantanes. In other words, it is believed to work by controlling movement problems by increasing the amount of dopamine in certain parts of the body. Summing up, it works by stopping the spread of influenza A virus in the body.

Hospital Vall Hebron leads this study about amantadine and COVID-19

Gobierno del principado de asturias supports this study about amantadine and COVID-19

Other Studies about Pharmacology:

ANTICOV Study : COVID-19 en Afrique

Collaborez avec l’étude ANTICOV et contribuez à traiter la COVID-19 en Afrique.

Progestérone pour traiter le COVID-19

Est-ce que les hormones sexuelles peuvent aider les hommes survivre le COVID-19 ? Cette étude a pour objectif évaluer la sécurité et l’efficacité de la…

E-speranza-COVID19 Project

This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.

CIBERESUCI COVID

CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.

Vaccination In People With Long COVID

This study aims to determine the effects of vaccination against SARS-CoV-2 in people with long COVID.

Antibiotic prescription during the COVID-19 pandemic

Antimicrobial stewardship approaches urgently need to be reinforced during the COVID-19 pandemic. This study evaluates the impact of the COVID-19 on antibiotic consumption.

Antihistamines and azithromycin as a treatment for COVID-19

This study suggests that primary care diagnosis and treatment with antihistamines, plus azithromycin in selected cases, may treat COVID-19 and prevent progression to severe disease…

Immunomodulatory Treatment In Patients With Severe Pneumonia COVID-19

Clinical trial to perform immunomodulatory treatment in adult patients with severe COVID-19 pneumonia with the aim of helping to define the standard treatment for this…

Real-life Use Of Remdesivir In Hospitalized Patients With COVID-19

This study aims to evaluate in clinical practice the efficacy and safety of remdesivir in patients admitted for COVID-19.

Prevention With Calcifediol Of Respiratory Problems Caused By COVID-19

This multicentre clinical trial aims to demonstrate that treatment with Calcifediol reduces the need for invasive ventilation and Intensive Care Unit admissions and deaths.